Jasmin’s research group develops computational models to study cancer evolution and mechanisms of treatment resistance to devise better personalised therapeutic strategies for cancer patients.
June 16, 2020
Jasmin’s research group develops computational models to study cancer evolution and mechanisms of treatment resistance to devise better personalised therapeutic strategies for cancer patients.
The Mark Foundation Institute for Integrated Cancer Medicine (MFICM) at the University of Cambridge aims to revolutionise cancer care by affecting patients along their treatment pathway.
